Telehealth vs Web-Based CBT for Insomnia
(CLEAR Trial)
Trial Summary
What is the purpose of this trial?
The objective of this RCT is to assess the efficacy of one-on-one telehealth CBT-I (tCBT-I) compared to web-based CBT-I (wCBT-I) and treatment as usual (TAU) to improve sleep outcomes (Aim 1), fatigue and quality of life (Aim 2), and promote neuroprotection (Exploratory Aim 3), and to explore the characteristics of participants that predict improvement in sleep outcomes (Exploratory Aim 4). Reassessment of outcomes will be completed after the 6-week intervention and 6 months following completion of interventions.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are taking benzodiazepines, non-benzodiazepines, or melatonin supplements for insomnia, you must have been on a stable dose for at least 3 months.
What data supports the effectiveness of the treatment Telehealth cognitive behavioral therapy for insomnia (tCBT-I)?
Research shows that telehealth and internet-based cognitive behavioral therapy for insomnia (CBT-I) can significantly improve sleep efficiency and reduce insomnia severity. Studies and meta-analyses indicate that tele-CBT-I is effective compared to face-to-face CBT-I and placebo, making it a promising option for those who cannot access traditional therapy.12345
Is digital cognitive behavioral therapy for insomnia (dCBT-I) safe for humans?
How does the treatment Telehealth vs Web-Based CBT for Insomnia differ from other treatments for insomnia?
This treatment is unique because it uses telehealth and web-based platforms to deliver cognitive behavioral therapy for insomnia (CBT-I), making it more accessible to people who may not have easy access to in-person therapy. It allows for both therapist-assisted and self-directed options, which can be more flexible and cost-effective compared to traditional face-to-face therapy.1231011
Research Team
Eligibility Criteria
This trial is for adults aged 18-65 with relapsing-remitting or secondary progressive MS, experiencing sleep issues at least three nights a week for the past three months. Participants should have mild-to-moderate disability, be English-speaking, and have internet access. Those with severe disabilities or other sleep disorders are excluded.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either telehealth-delivered CBT-I or web-based CBT-I for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Telehealth cognitive behavioral therapy for insomnia (tCBT-I) (Behavioral Intervention)
- Treatment as usual (TAU) (Behavioral Intervention)
- Web-based cognitive behavioral therapy for insomnia (wCBT-I) (Behavioral Intervention)
Telehealth cognitive behavioral therapy for insomnia (tCBT-I) is already approved in Canada for the following indications:
- Insomnia
- Sleep Disturbances
- Fatigue
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor
Dr. Steve Stites
University of Kansas Medical Center
Chief Executive Officer
MD from University of Kansas School of Medicine
Dr. Matthias Salathe
University of Kansas Medical Center
Chief Medical Officer
MD from University of Kansas School of Medicine